ABVC Biopharma Inc
NASDAQ:ABVC
ABVC Biopharma Inc
Revenue
ABVC Biopharma Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ABVC Biopharma Inc
NASDAQ:ABVC
|
Revenue
$152.4k
|
CAGR 3-Years
-32%
|
CAGR 5-Years
72%
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$28.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
Revenue
$1.8B
|
CAGR 3-Years
55%
|
CAGR 5-Years
89%
|
CAGR 10-Years
44%
|
|
Karuna Therapeutics Inc
NASDAQ:KRTX
|
Revenue
$654k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Moderna Inc
NASDAQ:MRNA
|
Revenue
$6.8B
|
CAGR 3-Years
104%
|
CAGR 5-Years
119%
|
CAGR 10-Years
N/A
|
|
Sarepta Therapeutics Inc
NASDAQ:SRPT
|
Revenue
$1.4B
|
CAGR 3-Years
35%
|
CAGR 5-Years
34%
|
CAGR 10-Years
57%
|
See Also
What is ABVC Biopharma Inc's Revenue?
Revenue
152.4k
USD
Based on the financial report for Dec 31, 2023, ABVC Biopharma Inc's Revenue amounts to 152.4k USD.
What is ABVC Biopharma Inc's Revenue growth rate?
Revenue CAGR 5Y
72%
Over the last year, the Revenue growth was -84%. The average annual Revenue growth rates for ABVC Biopharma Inc have been -32% over the past three years , 72% over the past five years .